I'm LongbridgeAI, I can summarize articles.Wall Street analysts initiated coverage on five stocks with bullish outlooks. BMO Capital rated VYLR Outperform ($85), Needham rated LBRX Buy ($68), Morgan Stanley rated ELVN Overweight ($70), Keybanc rated SAIL Sector Weight, and Raymond James rated AVLN Outperform ($60). These initiations reflect positive analyst sentiment for the listed companies.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BMO Capital analyst Joel Jackson initiated coverage on Vylor, Inc. (NYSE:VYLR) with an Outperform rating and announced a price target of $85. Vylor closed at $68.26 on Thursday. See how other analysts view this stock.
- Needham analyst Ami Fadia initiated coverage on LB Pharmaceuticals Inc (NASDAQ:LBRX) with a Buy rating and announced a price target of $68. LB Pharmaceuticals shares closed at $37.28 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Sean Laaman initiated coverage on Enliven Therapeutics Inc (NASDAQ:ELVN) with an Overweight rating and announced a price target of $70. Enliven Therapeutics closed at $46.21 on Thursday. See how other analysts view this stock.
- Keybanc analyst Eric Heath initiated coverage on Sailpoint Inc (NASDAQ:SAIL) with a Sector Weight rating. SailPoint shares closed at $20.58 on Thursday. See how other analysts view this stock.
- Raymond James analyst Tiago Fauth initiated coverage on Avalyn Pharma Inc (NASDAQ:AVLN) with an Outperform rating and announced a price target of $60. Avalyn Pharma closed at $27.42 on Thursday. See how other analysts view this stock.
Considering buying ELVN stock? Here’s what analysts think:
Photo via Shutterstock